Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium/Glucose Cotransporter Inhibitor 2”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Post-approval studies (Phase 4)Study completedNCT02700334
What this trial is testing

Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes

Who this might be right for
PrediabetesImpaired Fasting GlucoseImpaired Glucose Tolerance
University of Guadalajara 24
Not applicableActive Not RecruitingNCT07198191
What this trial is testing

SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study

Who this might be right for
Acute Myocardial Infarction (AMI)Type 2 Diabetes Mellitus (T2DM)
Yonsei University 200,000
Not applicableStudy completedNCT07269197
What this trial is testing

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Josip Juraj Strossmayer University of Osijek 67
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06655480
What this trial is testing

Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF

Who this might be right for
HFpEFLVDDMyocardial Fibrosis
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 50
Large-scale testing (Phase 3)Looking for participantsNCT05669742
What this trial is testing

Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients

Who this might be right for
Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics
Tanta University 40
Not applicableStudy completedNCT06432751
What this trial is testing

Pre-operative Exposure to SGLT2 Inhibitors and Post-operative Acute Renal Failure in Cardiac Surgery

Who this might be right for
Acute Kidney InjuryCardiac SurgerySodium/Glucose Cotransporter Inhibitor 2
Hospices Civils de Lyon 500
Large-scale testing (Phase 3)UnknownNCT05182658
What this trial is testing

Empagliflozin in Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic CardiomyopathyHeart Failure
National Institute of Cardiology, Warsaw, Poland 250
Very early researchLooking for participantsNCT06430684
What this trial is testing

Feasibility Trial of Sodium-GLucose CoTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

Who this might be right for
Chronic Kidney DiseasesPediatric Kidney Disease
Ann & Robert H Lurie Children's Hospital of Chicago 40
Testing effectiveness (Phase 2)Study completedNCT03316131
What this trial is testing

Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA

Who this might be right for
Asymptomatic Hyperuricemia
AstraZeneca 36
Large-scale testing (Phase 3)WithdrawnNCT06560333
What this trial is testing

ISGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD)

Who this might be right for
Diabetes Mellitus, Type 2
Eurofarma Laboratorios S.A.
Post-approval studies (Phase 4)Active Not RecruitingNCT05590143
What this trial is testing

ProMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2

Who this might be right for
Acute Kidney InjuryCardiac SurgerySodium-Glucose Transporter 2 Inhibitor
Amsterdam UMC 784
Not applicableStudy completedNCT02966626
What this trial is testing

A Real World Experience of Dapagliflozin in Type 2 Diabetes

Who this might be right for
Type2 Diabetes
University of Malaya 223
Testing effectiveness (Phase 2)UnknownNCT04419337
What this trial is testing

Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke

Who this might be right for
Diabetes MellitusStroke
Chang Gung Memorial Hospital 200
Post-approval studies (Phase 4)Study completedNCT06825156
What this trial is testing

Metabolic and Renal Outcomes in Cardiac Surgery Patients Receiving SGLT2 Inhibitors

Who this might be right for
Acute Kidney Injury
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 60
Post-approval studies (Phase 4)Looking for participantsNCT05612594
What this trial is testing

Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA Study

Who this might be right for
Sleep Apnea
Yale University 164
Post-approval studies (Phase 4)Looking for participantsNCT05672836
What this trial is testing

ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement

Who this might be right for
Aortic Valve StenosisHeart Failure
Duk-Woo Park, MD 1,040
Not applicableStudy completedNCT03473262
What this trial is testing

Empagliflozin-based Quadruple Combination vs Insulin Glarine-based Combination Therapy in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Chungbuk National University Hospital 200
Post-approval studies (Phase 4)Looking for participantsNCT06668389
What this trial is testing

Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial

Who this might be right for
Congenital Heart DiseaseRepaired Tetralogy of Fallot (rTOF)Pulmonary Regurgitation+2 more
The University of Hong Kong 106
Post-approval studies (Phase 4)Study completedNCT02360774
What this trial is testing

Mechanisms of Weight Loss With SGLT2 Inhibition

Who this might be right for
Type 2 DiabetesOverweightObesity
Beth Israel Deaconess Medical Center 30
Early research (Phase 1)Study completedNCT06828731
What this trial is testing

Evaluation of Empagliflozin vs Standard Care in Veterans With Prediabetes

Who this might be right for
Prediabetes
Charles George VA Medical Center 60
Load More Results